Author | Wayne Kuznar

Articles

Water vapor thermal therapy results found durable at 5 years

May 14, 2020

Article

The benefits of minimally invasive water vapor thermal therapy (Rezūm System) on lower urinary tract symptoms due to benign prostatic hyperplasia are durable, with a reduction in symptom score and an improvement in flow rate sustained to 5 years, according to researchers.

6-month progression is strong survival surrogate in mHSPC

May 14, 2020

Article

Disease progression within 6 months was the strongest surrogate marker for overall survival in patients with metastatic hormone-sensitive prostate cancer treated with combination therapy in a retrospective analysis of the CHAARTED trial.

RP leads to better survival vs radiation from time of metastasis

May 13, 2020

Article

Compared with local radiation therapy, radical prostatectomy as primary treatment for prostate cancer may result in a lower risk of castration-resistant disease and superior overall survival from the time of metastasis.

Neoadjuvant durvalumab feasible in muscle-invasive bladder Ca

April 09, 2020

Article

Durvalumab (IMFINZI) appears to be feasible as neoadjuvant therapy with preliminary evidence of antitumor activity in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.